LNP Lipid Composition & Molar Ratio Analysis Services

Quantifying the precise molar stoichiometry of all four lipid components in lipid nanoparticles (LNPs) is essential for predicting biological efficacy, maintaining critical N/P ratios, and meeting stringent regulatory CMC thresholds. Creative Proteomics offers verified single-run quantitative assays by RP-UHPLC-CAD and high-resolution LC-MS/MS, resolving ionizable lipids, helper phospholipids, cholesterol, and PEGylated lipids in formulated nanomedicines.

Why choose us: Simultaneous 4-in-1 quantification · universal mass-sensitive CAD response · baseline separation of PEG-lipid polydispersity · microfluidic DOE support

What we provide: Absolute concentration (mg/mL) · certified molar percentage (mol%) · true N/P ratio calculations · lyso-lipid & degradant tracking

Problems we solve: Formulation drift during TFF · PEG-lipid surface shedding · unreacted ionizable raw material impurities · non-chromophoric cholesterol quantification

Request Analysis

Submit Your Request Now

×

Our services have earned the trust of companies, schools, and organizations globally, and we remain dedicated to maintaining that trust.

Boston University
University at Buffalo
UMass Medical School
Hawaii Pacific University
Medizinische Fakultät
Louisiana State University
NYU Langone
Nature's Fynd
Dietary supplement manufacturer
  • Service We Provide
  • 4 Lipid Classes
  • Methods
  • Workflow
  • Results and Data Analysis
  • Sample Requirements
  • FAQ

Why LNP Lipid Composition & Molar Ratio Matters

In lipid nanoparticle (LNP) formulations, biological potency is dictated by the precise stoichiometric assembly of four distinct lipid entities. While theoretical calculations assume 100% encapsulation and uniform assembly, physical realities during microfluidic mixing, ultrafiltration, and storage inevitably introduce composition drift.

A standard LNP comprises an ionizable cationic lipid (typically 40–50 mol%), a neutral helper phospholipid (e.g., DSPC or DOPE, ~10 mol%), cholesterol (38–40 mol%), and a PEGylated lipid (1.0–2.0 mol%). Minor variations in the actual molar ratio profoundly shift formulation critical quality attributes (CQAs). A 2% depletion in ionizable lipid decreases the effective N/P ratio, leading to premature cargo release or incomplete encapsulation. Conversely, preferential loss or excessive desorption of PEG-lipids alters average particle diameter (Z-average), polydispersity index (PDI), and circulation half-life. Our quantitative service bridges the gap between nominal recipe formulation and actual nanoparticle composition through verified single-run chromatographic analysis.

Where formulation screening focuses on traditional bilayer vesicles without nucleic acid condensation cores, characterization is supported through our liposome characterization services. For downstream systemic biodistribution and tissue-level trafficking, studies can be paired with our LNP & exosome delivery profiling.

LNP Lipid Composition Services in Creative Proteomics

At Creative Proteomics, we offer specialized analytical modules tailored for biopharmaceutical research, drug product development, and academic nanomedicine programs.

Stoichiometric Molar Ratio Determination

Accurate quantification of absolute concentration (mg/mL) and relative molar fraction (mol%) for all 4 lipid classes in a single chromatographic separation.

Effective N/P Ratio Calculation

Direct correlation of measured intact ionizable lipid molarity against cargo nucleic acid phosphate concentration to certify true functional N/P stoichiometry.

Encapsulated vs. Free Lipid Fractionation

Centrifugal ultrafiltration and solid-phase extraction protocols separating intact assembled particles from free unencapsulated lipid monomers.

PEG-Lipid Shedding & Stability Profiling

Quantitative tracking of PEG-lipid desorption kinetics in serum or storage buffer over accelerated stability and freeze-thaw cycles.

Degradation & Hydrolysis Impurity Tracking

Simultaneous profiling of lyso-phospholipids (LPC, LPE), oxidized sterols, and cleaved ionizable lipid tails in degraded LNP lots.

Batch-to-Batch Comparability

Assessing formula reproducibility across microfluidic batches, scale-up runs, and storage conditions with certified calibration curves and internal standard control.

Four Lipid Classes Quantified in LNP Formulations

Each of the four lipid components governs a distinct biological and structural mechanism in nucleic acid delivery. Below are the quantitative targets and analytical methodologies.

  • Ionizable Lipids
  • Helper Phospholipids
  • Sterol Component
  • PEGylated Lipids

Ionizable Cationic Lipids & Charge Distribution

The ionizable lipid represents the functional cornerstone of LNP technology, engineered with an apparent pKa between 6.0 and 7.0. It condenses mRNA/siRNA in acidic mixing conditions and triggers endosomal membrane destabilization inside target cells.

Analytical Feature Specification & Details
Representative Targets DLin-MC3-DMA (MC3), ALC-0315, SM-102, C12-200, LP01, and custom proprietary synthetic ionizable lipids
Critical Readouts Absolute concentration (mg/mL), actual mol%, unreacted raw materials, and N-oxide / hydrolysis degradants
Analytical Method RP-UHPLC with Charged Aerosol Detection (CAD) and high-resolution Q Exactive Orbitrap MS/MS confirmation

Helper Neutral Phospholipids (DSPC / DOPE)

Zwitterionic helper lipids support lamellar bilayer phase integrity. DSPC provides high phase transition temperatures ensuring rigid encapsulation, whereas unsaturated DOPE adopts non-lamellar hexagonal II structures that promote membrane fusion. When comprehensive fatty acid chain distribution or lysolipid degradation profiling is required alongside intact ratios, analysis can be coupled with our phosphatidylcholine analysis and phosphatidylethanolamine analysis workflows.

Analytical Feature Specification & Details
Representative Targets 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), DPPC
Critical Readouts Phospholipid mass concentration, molar ratio percentage, and accumulation of lyso-phospholipids (LPC / LPE)
Analytical Method HILIC and reversed-phase UHPLC with CAD mass quantification and tandem MS verification

Sterol Component (Cholesterol & Analogues)

Cholesterol fills interstitial voids between bulky acyl chains, preventing payload leakage, enhancing structural integrity, and modulating intracellular trafficking kinetics. For broader investigations into sterol purity, precursor accumulation, or oxidation products, assays are supported by our dedicated cholesterol targeted lipidomics platform.

Analytical Feature Specification & Details
Representative Targets Cholesterol (plant-derived or synthetic), β-sitosterol, 7-dehydrocholesterol, and oxidized sterol impurities
Critical Readouts Zero native UV chromophore at standard wavelengths; quantified via CAD mass response or atmospheric pressure chemical ionization (APCI) MS
Analytical Method Reversed-phase UHPLC with CAD universal mass response or APCI-MS/MS for non-chromophoric sterols

PEGylated Lipids & Surface Shedding

PEG-conjugated lipids typically comprise only 1.0–2.0 mol% of the total formulation. Despite low molarity, PEG length and anchor chain length (C14 vs C18) dictate particle diameter and in vivo circulation half-life. Complementary raw material verification and phospholipid backbone characterization can also be correlated through our phospholipids analysis service.

Analytical Feature Specification & Details
Representative Targets 1,2-dimyristoyl-rac-glycero-3-methoxypolyethylene glycol-2000 (DMG-PEG2000), ALC-0159, DSPE-mPEG2000
Critical Readouts Polydispersity deconvolution, true PEG-lipid recovery post-TFF purification, and desorption kinetics monitoring
Analytical Method RP-UHPLC with post-column inverse gradient CAD and high-resolution Orbitrap mass deconvolution

Methods Used for LNP Lipid Composition Analysis

Comparing UV, CAD, and LC-MS/MS for LNP Lipid Quantification

Accurate molar ratio certification requires analytical detectors whose response factors do not depend on optical absorption. The table below outlines detector performance across LNP quality attributes.

Parameter / Feature Standard HPLC-UV Charged Aerosol Detection (CAD) Triple Quad LC-MS/MS High-Res Orbitrap MS
Chromophore Dependency Mandatory (>210 nm) Universal (non-volatile mass) None (ionization dependent) None (exact mass)
Sterol & Saturated Sensitivity Very poor / undetected High and uniform Moderate (requires APCI) High (sub-ppm mass accuracy)
Dynamic Linear Range Narrow at low UV Wide (>3 orders with power fit) Wide (>4 orders) Wide (>3 orders)
Solvent Gradient Compatibility Baseline drift with THF/IPA Inverse gradient compensation High tolerance High tolerance
Ideal Project Application Crude screening of aromatic targets Simultaneous 4-in-1 mol% assay Trace biodistribution in tissues Impurity & N-oxide confirmation

Orthogonal comparison of chromatographic detection modalities for LNP characterizationOrthogonal detection comparison: highlighting CAD uniform response for simultaneous quantification of cholesterol, phospholipids, PEG-lipids, and ionizable cationic lipids without chromophore extinction bias.

Why Choose Our LNP Composition & Molar Ratio Services?

  • Single-Injection 4-Component Resolution: Baseline separation of ionizable lipid, helper lipid, cholesterol, and PEG-lipid on charged-surface hybrid (CSH) C18 columns in under 20 minutes.
  • Uniform CAD Response Factor: Overcoming optical chromophore deficiencies to quantify cholesterol and saturated phospholipids without differential molar extinction bias.
  • Inverse Gradient Solvent Compensation: Maintaining constant nebulization temperature and mobile phase composition across steep organic gradients for flat analytical baselines.
  • Direct Functional N/P Ratio Output: Calculation of effective charge ratios using verified, intact ionizable lipid molarity rather than theoretical formulation inputs.
  • Low Sample Consumption: Validated micro-analytical methods requiring as little as 50–100 μL of formulated LNP bulk drug product.
  • Full Degradation Profile Reporting: Concomitant quantification of hydrolytic lyso-lipids, sterol oxidation products, and trace amine N-oxides.

Typical Workflow of LNP Composition Quantification

Workflow for LNP lipid composition and molar ratio testingComprehensive five-stage testing workflow: from non-destructive sample preparation and single-run UHPLC-CAD separation to certified molar ratio reporting and regulatory submission support.

Our quantitative workflow is engineered to minimize sample handling artefacts and avoid premature lipid oxidation. Samples undergo mild organic disruption before automated auto-sampler injection. Run data are processed using power-function calibration models against certified primary reference standards, yielding quantitative molar tables and CQA comparability indices.

Analytical Platforms for LNP Composition Analysis

Thermo Fisher Vanquish Horizon UHPLC with CAD

Thermo Scientific Vanquish Horizon UHPLC + CAD
Biocompatible fluidics paired with CAD for uniform non-volatile lipid response

Thermo Fisher Q Exactive HF-X Hybrid Quadrupole-Orbitrap MS

Thermo Fisher Q Exactive HF-X Orbitrap MS
High-resolution mass spectrometry (<2 ppm) for structural verification

Chromatographic & Spectrometric Method Parameters

Parameter Analytical Condition Technical Significance
Stationary Phase Waters ACQUITY Premier CSH C18 (2.1 × 100 mm, 1.7 μm) Positively charged surface prevents peak tailing of basic ionizable lipids
Mobile Phase A / B Water / Acetonitrile / Isopropanol with 0.1% Formic Acid & 10 mM Ammonium Formate Maintains ion-pairing control and optimizes CAD aerosol evaporation kinetics
Gradient Scheme Inverse gradient with secondary pump compensation (50–100% B over 16 min) Neutralizes nebulizer response changes across steep organic elutions
CAD Settings Evaporator temp: 35°C; Data rate: 10 Hz; Filter: 3.6 s; Power function: 1.20–1.45 Linearizes non-linear mass response curves across 0.5–500 μg/mL range

LNP Composition Analysis Service: Results and Data Analysis

Simultaneous Chromatographic Separation & Molar Certification

Results we provide:

  • Absolute concentration (mg/mL or mM) for each of the 4 lipid components.
  • Calculated molar percentage (mol%) normalized to total quantified lipids.
  • Comparison of measured stoichiometry against nominal feed ratio with % recovery.
  • Certified functional N/P ratio based on intact ionizable lipid molarity.
  • Lyso-phospholipid (LPC, LPE) and degradation product content.

Data analysis:

  • Overlay chromatograms displaying baseline peak resolution for all four lipid entities.
  • Power function non-linear regression curves with R² > 0.998 goodness-of-fit.
  • Statistical batch comparability charts illustrating formulation consistency.
Baseline separation of LNP lipid components

Baseline separation of 4 LNP lipid components on CSH C18 with CAD detection.

Molar ratio certification and batch comparability radar plot

Molar ratio certification comparing measured mol% against nominal recipe values.

Applications for LNP Composition Profiling

Microfluidic Formulation Screening & DOE

In Design-of-Experiments (DOE) exploring total flow rate (TFR), flow rate ratio (FRR), and aqueous-to-solvent ratios, our molar ratio testing directly verifies whether mixer physics faithfully translates target recipes into intended nanoparticle structures.

TFF Purification & Downstream Recovery

Tangential flow filtration (TFF) and diafiltration frequently strip weakly anchored PEG-lipids. Monitoring the four lipids across diafiltration volumes pinpoints membrane retention cut-offs and optimizes washing parameters.

Accelerated Stability & Stress Testing

Quantify ester cleavage, phospholipid hydrolysis, and PEG desorption under thermal, acidic, and freeze-thaw stresses to establish shelf-life boundaries and container closure compatibility.

Preclinical CMC Dossier Characterization

Deliver robust chromatographic and spectrometric documentation of formulation stoichiometry and impurity limits to de-risk IND-enabling preclinical studies and academic grant milestones.

Sample Requirements for LNP Composition Analysis

Parameter Requirement / Recommendation
Sample Matrix Formulated LNPs (suspension), crude microfluidic reaction mixtures, or raw lipid mixtures
Minimum Volume / Mass 50–200 μL per replicate (minimum total lipid concentration >0.2 mg/mL)
Buffer Compatibility PBS, Tris, citrate, sucrose/trehalose cryoprotectants (lyophilized or liquid)
Shipping Conditions Frozen on dry ice (−80°C) or refrigerated cold packs (±4°C) depending on stability profile
Documentation Needed Target recipe molar ratios, candidate ionizable lipid chemical structure or formula weight

FAQs for LNP Lipid Composition & Molar Ratio Service

Why can't HPLC with standard UV detection accurately quantify all four LNP lipids?

Standard UV detectors rely on chromophores (such as aromatic rings or conjugated double bonds) to absorb light. Cholesterol and saturated helper phospholipids (such as DSPC or DPPC) possess no native chromophores and yield virtually zero absorbance above 210 nm. Monitoring at 200–205 nm causes severe baseline drift and baseline noise from organic mobile phases. Charged Aerosol Detection (CAD) is a universal mass-sensitive technology that measures particle charge proportional to analyte mass, ensuring accurate, uniform response factors across all lipid classes without chromophore bias.

How does actual molar ratio determination impact the N/P ratio calculation?

The N/P ratio represents the molar ratio of positively charged ionizable amine groups (N) to negatively charged nucleic acid phosphate backbones (P). By measuring the exact molarity of the intact, non-degraded ionizable lipid in your formulated sample and combining it with your known or measured cargo concentration, we calculate the true functional N/P ratio.

What is the typical turnaround time for LNP composition testing?

Standard turnaround time for established LNP compositions (e.g., MC3, SM-102, ALC-0315 formulations) is 10–15 business days following sample receipt. Expedited testing is available upon request for time-sensitive formulation screening campaigns.

What development stages does this service support?

Our compositional and molar ratio analysis platform supports early discovery, preclinical formulation optimization, process development, and comparative stability evaluation. We deliver comprehensive research-grade characterization data to accelerate candidate selection and formulation refinement.

References

  1. Kinsey, C., et al. "RP-CAD for Lipid Quantification: Systematic Method Development, Calibration, and Validation across LNP Processing." Pharmaceuticals 17(9), 1217 (2024). https://doi.org/10.3390/ph17091217
  2. Pack, C. G., et al. "A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems: ionizable lipid N-oxide formation." Nature Communications 12, 6777 (2021). https://doi.org/10.1038/s41467-021-26926-7
* Our services can only be used for research purposes and Not for clinical use.

Applications:


Online Inquiry

CONTACT US

  • USA
  • Tel: 1-631-275-3058 (USA)
  • Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
  • Email:
  • Fax: 1-631-614-7828
  • Germany
  • Address: 65830 Kriftel, Gutenbergstraße 5. Frankfurt am Main, Germany
Copyright © 2026 Creative Proteomics. All rights reserved.